Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-315
Closed -$3.03K 1600
2023
Q1
$3.03K Buy
315
+220
+232% +$2.44K ﹤0.01% 1349
2022
Q4
$1.06K Sell
95
-872
-90% -$9.11K ﹤0.01% 1511
2022
Q3
$8K Buy
+967
New +$9.52K ﹤0.01% 1089
2022
Q1
Sell
-427
Closed -$6K 1648
2021
Q4
$6K Buy
427
+4
+0.9% +$53 ﹤0.01% 972
2021
Q3
$6K Buy
423
+3
+0.7% +$43 ﹤0.01% 938
2021
Q2
$6K Buy
420
+3
+0.7% +$43 ﹤0.01% 876
2021
Q1
$6K Sell
417
-12
-3% -$196 ﹤0.01% 882
2020
Q4
$8K Buy
+429
New +$7K ﹤0.01% 776

Other funds holding VTRS

Ellevest Inc's VTRS Position: Q2 2023 in Review

Ellevest Inc sold out of Viatris (VTRS) in Q2 2023, closing a stake of 315 shares — an estimated $3.03K sold.

Ellevest Inc first reported a position in VTRS in Q4 2020 and held it in 8 quarters. The position peaked at $8K in Q3 2022. 986 funds tracked by Wall St. Rank hold VTRS as of Q2 2023.

  • Ellevest Inc reported no remaining Viatris position as of Q2 2023 after selling out during the quarter.
  • Ellevest Inc sold 315 Viatris shares in Q2 2023, an estimated $3.03K.
  • Ellevest Inc first reported a position in Viatris in Q4 2020 and held it in 8 quarters.
  • Ellevest Inc's Viatris position peaked at $8K in Q3 2022.
  • 986 funds tracked by Wall St. Rank held Viatris as of Q2 2023.

Based on Ellevest Inc's 13F filing for Q2 2023, filed 9 Aug 2023.